254 related articles for article (PubMed ID: 36385600)
1. Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies.
Mok CC; Ho LY; Tse SM; Chan KL; To CH
Clin Rheumatol; 2023 Apr; 42(4):1019-1026. PubMed ID: 36385600
[TBL] [Abstract][Full Text] [Related]
2. Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia.
Liao TL; Chen YM; Liu HJ; Chen DY
BMJ Open; 2017 Jan; 7(1):e014032. PubMed ID: 28057661
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
Hu SC; Yen FL; Wang TN; Lin YC; Lin CL; Chen GS
J Am Acad Dermatol; 2016 Jul; 75(1):49-58. PubMed ID: 26946984
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and risk factors of herpes zoster infection in patients with biopsy proven lupus nephritis undergoing immunosuppressive therapies.
Mok CC; Tse SM; Chan KL; Ho LY
Lupus; 2020 Jul; 29(8):836-844. PubMed ID: 32408851
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for herpes zoster infection among Filipinos with systemic lupus erythematosus.
Zamora LD; Collante MTM; Navarra SV
Int J Rheum Dis; 2020 Feb; 23(2):197-202. PubMed ID: 31692250
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for herpes zoster in patients with rheumatic diseases: a nationwide cohort study in Korea.
Ryu HJ; Han JO; Lee SA; Seo MR; Choi HJ; Ko KP; Baek HJ
Rheumatology (Oxford); 2021 May; 60(5):2427-2433. PubMed ID: 33232486
[TBL] [Abstract][Full Text] [Related]
7. Incidence, risk factors, and outcome of Herpes zoster in systemic lupus erythematosus.
Borba EF; Ribeiro AC; Martin P; Costa LP; Guedes LK; Bonfá E
J Clin Rheumatol; 2010 Apr; 16(3):119-22. PubMed ID: 20216330
[TBL] [Abstract][Full Text] [Related]
8. Herpes zoster in juvenile-onset systemic lupus erythematosus: incidence, clinical characteristics and risk factors.
Lee PP; Lee TL; Ho MH; Wong WH; Lau YL
Pediatr Infect Dis J; 2006 Aug; 25(8):728-32. PubMed ID: 16874173
[TBL] [Abstract][Full Text] [Related]
9. Close association of herpes zoster reactivation and systemic lupus erythematosus (SLE) diagnosis: case-control study of patients with SLE or noninflammatory musculoskeletal disorders.
Pope JE; Krizova A; Ouimet JM; Goodwin JL; Lankin M
J Rheumatol; 2004 Feb; 31(2):274-9. PubMed ID: 14760796
[TBL] [Abstract][Full Text] [Related]
10. Increased incidence of herpes zoster among patients with systemic lupus erythematosus.
Chakravarty EF; Michaud K; Katz R; Wolfe F
Lupus; 2013 Mar; 22(3):238-44. PubMed ID: 23257402
[TBL] [Abstract][Full Text] [Related]
11. Herpes zoster in systemic lupus erythematosus.
Manzi S; Kuller LH; Kutzer J; Pazin GJ; Sinacore J; Medsger TA; Ramsey-Goldman R
J Rheumatol; 1995 Jul; 22(7):1254-8. PubMed ID: 7562754
[TBL] [Abstract][Full Text] [Related]
12. [Herpes zoster in connective tissue diseases: I. Association with systemic lupus erythematosus and its immunological abnormalities].
Yamauchi Y; Nagasawa K; Tada Y; Tsukamoto H; Yoshizawa S; Mayumi T; Niho Y; Kusaba T
Kansenshogaku Zasshi; 1991 Jul; 65(7):851-6. PubMed ID: 1655920
[TBL] [Abstract][Full Text] [Related]
13. Real-World Coverage With Influenza, Pneumococcal, and Herpes Zoster Vaccines Among Patients With Rheumatic Diseases in a Nationwide Healthcare Plan.
Furer V; Weil C; Chodik G; Slav SA; Blonder SN; Fisher-Shoval Y; Barak M; Elkayam O
J Rheumatol; 2024 May; 51(5):505-516. PubMed ID: 38302167
[TBL] [Abstract][Full Text] [Related]
14. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis reactivation in patients with rheumatic diseases after immunosuppressive therapy--a report of long-term follow-up of serial cases and literature review.
Xuan D; Yu Y; Shao L; Wang J; Zhang W; Zou H
Clin Rheumatol; 2014 Apr; 33(4):577-86. PubMed ID: 24343455
[TBL] [Abstract][Full Text] [Related]
16. Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy.
Yun H; Xie F; Delzell E; Chen L; Levitan EB; Lewis JD; Saag KG; Beukelman T; Winthrop K; Baddley JW; Curtis JR
Arthritis Care Res (Hoboken); 2015 May; 67(5):731-6. PubMed ID: 25201241
[TBL] [Abstract][Full Text] [Related]
17. Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database.
Sfikakis PP; Bournia VK; Sidiropoulos P; Boumpas DT; Drosos AA; Kitas GD; Konstantonis G; Liossis SN; Manoussakis MN; Sakkas L; Tektonidou M; Tzioufas AG; Vlachoyiannopoulos PG; Kani C; Paterakis P; Litsa P; Vassilopoulos D
Clin Exp Rheumatol; 2017; 35(4):579-585. PubMed ID: 28281458
[TBL] [Abstract][Full Text] [Related]
18. Safety of JAK inhibitor use in patients with rheumatoid arthritis who developed herpes zoster after receiving JAK inhibitors.
Choi W; Ahn SM; Kim YG; Lee CK; Yoo B; Hong S
Clin Rheumatol; 2022 Jun; 41(6):1659-1663. PubMed ID: 35157164
[TBL] [Abstract][Full Text] [Related]
19. Herpes Zoster Reactivation in Patients With Rheumatoid Arthritis: Analysis of Disease Characteristics and Disease-Modifying Antirheumatic Drugs.
Pappas DA; Hooper MM; Kremer JM; Reed G; Shan Y; Wenkert D; Greenberg JD; Curtis JR
Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1671-8. PubMed ID: 26018115
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of immune suppression in patients with systemic lupus erythematosus complicated by herpes zoster virus infection].
Ouyang H; He XC; Zhou Y; Li ZX
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Nov; 36(11):1577-1581. PubMed ID: 27881354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
